about
Gut microbiota and metabolic syndromeThe application of omics technologies in the functional evaluation of inulin and inulin-containing prebiotics dietary supplementationThe influence of the human microbiome and probiotics on cardiovascular healthEpigenetic effects of human breast milk.The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications.Dietary xylo-oligosaccharide stimulates intestinal bifidobacteria and lactobacilli but has limited effect on intestinal integrity in rats.Shifts in microbiota species and fermentation products in a dietary model enriched in fat and sucrose.Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.The intestinal microbiome and skeletal fitness: Connecting bugs and bonesOral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the LiverLactobacillus casei Shirota Supplementation Does Not Restore Gut Microbiota Composition and Gut Barrier in Metabolic Syndrome: A Randomized Pilot Study.Characterisation of the gastrointestinal mucosa-associated microbiota: a novel technique to prevent cross-contamination during endoscopic procedures.Distinctive gut microbial community structure in both the wild and farmed Swan goose (Anser cygnoides).Brazilian propolis mitigates impaired glucose and lipid metabolism in experimental periodontitis in mice.Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.Natural history of the infant gut microbiome and impact of antibiotic treatment on bacterial strain diversity and stabilityReduced microbial diversity in adult survivors of childhood acute lymphoblastic leukemia and microbial associations with increased immune activation.The effects of probiotic and synbiotic supplementation on metabolic syndrome indices in adults at risk of type 2 diabetes: study protocol for a randomized controlled trialNutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan.The human gut microbiome in health: establishment and resilience of microbiota over a lifetime.Constraint-based stoichiometric modelling from single organisms to microbial communities.Understanding the role of the gut ecosystem in diabetes mellitus.Analysis and comparison of the wolf microbiome under different environmental factors using three different data of Next Generation Sequencing.An Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases.Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions.Ligature-induced periodontitis in mice induces elevated levels of circulating interleukin-6 but shows only weak effects on adipose and liver tissues.The distinct effects of orally administered Lactobacillus rhamnosus GG and Lactococcus lactis subsp. lactis C59 on gene expression in the murine small intestine.Probiotics in Gut-Bone Signaling.Gut Microbiota-Derived Short Chain Fatty Acids Induce Circadian Clock Entrainment in Mouse Peripheral Tissue.Advances in Probiotic Regulation of Bone and Mineral Metabolism.The Microbiome That Shapes Us: Can It Cause Obesity?The Potential of Probiotics as a Therapy for Osteoporosis.The influence of diet on anti-cancer immune responsiveness.Effects of xylo-oligosaccharide and flavomycin on the immune function of broiler chickens.Phytochemicals as antibiotic alternatives to promote growth and enhance host health
P2860
Q24563886-1CDA554B-D1DC-4BE1-A2C1-B964240BDB13Q26775964-E8EC4A72-CB88-4B1D-A184-C2827E4F98DEQ26992191-239B4E12-774F-488B-AB91-0B7894EA13F1Q33570511-2367B020-BF31-40E3-8F3F-58E071671851Q33670800-601C5CAE-F4BB-4CCE-8794-EDF853B987C5Q34265824-A4C1029E-CCD1-4718-9B6F-5DA01475FC5EQ35248770-7C6B488D-80CF-47B6-AD5C-C1EE18C66D8CQ35359043-8AF15C2F-C447-40E2-AC3C-ABD7B04D6F70Q35530569-FAD2914F-522E-4040-84E6-452B54FCBF63Q35594858-81E7163B-9F50-481F-886D-E96ABE0852F9Q35719237-D70762B3-4267-46E7-8600-B383C4371155Q35824398-F6C0D690-EDFC-4620-B41D-1FE0A33B21D0Q35992014-46C7F846-E6EE-42E1-A3DF-29ACEA0D0397Q36065504-3BD7B413-9DC2-4D1F-B35B-3495600BEA3FQ36117228-DD2BB16C-DDEA-4876-96C2-3D545C6CB369Q36207356-3B017B14-46FB-46E5-B726-FD2B7835E5DDQ37275280-8118B378-F754-4B0F-BB68-216DA126A606Q37713517-BD806D7B-027B-40F7-9C7F-7BE974EB7422Q37728632-D89EA0D0-F912-44EE-BFCE-1EA534377EEBQ38231113-68BA07F9-AF2C-4978-93C5-96B7034332D0Q38802303-8C898BC1-CD2B-4682-B468-DAE0D5D3EC4BQ39196318-072BC769-D2DB-4030-A03B-0050D5F99BD2Q39228112-7C57AE69-C972-456E-9CCD-A300901ECA35Q41191993-6B49173F-A4D8-4E51-BDF4-1613AE8575D0Q42343448-CA3823C5-D0B3-4273-8509-9966EEC53735Q46267304-85131868-403D-432E-9AF2-0AFCBF510AB4Q46623982-15FBC541-9053-4FFE-B1D4-F7B0122D6064Q47343508-3BE35EE8-A221-4342-8BC9-F0B473DC2620Q48511475-B03C2B4F-8674-47B8-9EFE-8A330B339C4BQ49699502-AC1256BB-4DDF-40D3-9940-8E7873E975E9Q49908196-6C7DFBE6-07B5-452E-979C-7220EBAC091DQ50100624-20276CD9-02B9-4093-B3FD-7CD380CC67DFQ51800938-B8124054-0693-457B-9513-53F8E6BF8738Q53700576-739FB5C0-EAE6-4E41-9206-07F904BEA0D1Q55019014-D57ABCB5-F9EC-468D-92DE-B7150A052147Q57865609-761BD13E-846A-44B5-84AF-814A54D45699
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Gut microbiome and metabolic diseases.
@ast
Gut microbiome and metabolic diseases.
@en
type
label
Gut microbiome and metabolic diseases.
@ast
Gut microbiome and metabolic diseases.
@en
prefLabel
Gut microbiome and metabolic diseases.
@ast
Gut microbiome and metabolic diseases.
@en
P2860
P1476
Gut microbiome and metabolic diseases
@en
P2093
Shinji Fukuda
P2860
P2888
P304
P356
10.1007/S00281-013-0399-Z
P50
P577
2013-11-06T00:00:00Z